Pantelis Tsirkinidis

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Christina Kalpadakis, Gerassimos A. Pangalis, Sotirios Sachanas et al. · Blood · 2018 · 59 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen

Sotirios Sachanas, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 36 citations

Medicine, Oncology, Pharmacotherapy +11

Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas

Maria Dimou, Sotirios G. Papageorgiou, Niki Stavroyianni et al. · Hematological Oncology · 2021 · 36 citations

Medicine, Pharmacology, Pharmacotherapy +16

Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens

Theodoros P. Vassilakopoulos, Maria Dimopoulou, Maria K. Angelopoulou et al. · The Oncologist · 2016 · 26 citations · Full text

Medicine, Hematology, Oncology +12

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, Maria K. Angelopoulou et al. · Annals of Hematology · 2021 · 26 citations

Medicine, Nuclear Medicine, Oncology +16